Dr Hill on the Use of Carfilzomib With R-CHOP in DLBCL
Brian T. Hill, MD, PhD, discusses the final results from a phase 1/2 trial of carfilzomib given with R-CHOP in the frontline setting for patients with non-germinal center diffuse large B-cell lymphoma.
Briant Hill Cleveland Clinic Taussig Cancer Institute Lymphoid Malignancies Program Cleveland Clinic Onclive Tv Hematologic Malignancies
Source: onclive.com